Thursday Nov 30, 2023

Inside the FDA ODAC ’Yes’ Vote to Polivy

In this episode of The HemOnc Pulse, Grzegorz Nowakowski MD, a Professor of Oncology and Medicine in the Division of Hematology at the Mayo Clinic, recounts his experience serving on the FDA Oncologic Drugs Advisory Committee that reviewed and evaluated data from the POLARIX study and polatuzumab vedotin-piiq (Polivy)for patients with previously untreated LBCL.

Comments (0)

To leave or reply to comments, please download free Podbean or

No Comments

Copyright 2024 All rights reserved.

Podcast Powered By Podbean

Version: 20240731